Allogeneic CD19-Specific T Cells (from peripheral blood)

CD19-targeted T cells (allogeneic) · MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CD19-Specific T Cells (from peripheral blood), covering 2025-03-13 to 2025-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood [Phase 1]

See pricing